MRNS
Marinus Pharmaceuticals Inc
Price:  
0.54 
USD
Volume:  
1,747,439.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS WACC - Weighted Average Cost of Capital

The WACC of Marinus Pharmaceuticals Inc (MRNS) is 5.5%.

The Cost of Equity of Marinus Pharmaceuticals Inc (MRNS) is 6.30%.
The Cost of Debt of Marinus Pharmaceuticals Inc (MRNS) is 7.00%.

Range Selected
Cost of equity 5.10% - 7.50% 6.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.1% - 5.8% 5.5%
WACC

MRNS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.16 0.39
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.10% 7.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 2.46 2.46
Cost of debt 7.00% 7.00%
After-tax WACC 5.1% 5.8%
Selected WACC 5.5%